Yost 女性自我报告下肢淋巴水肿筛查问卷的荷兰语翻译。
Dutch Translation of the Yost Self-Report Lower Extremity Lymphedema Screening Questionnaire in Women.
发表日期:2024 Jun 28
作者:
Tina Decorte, Charlotte Van Calster, Caren Randon, Vickie Van Besien, Mathilde Ketels, Luc Vanden Bossche, Mieke De Schryver, Chris Monten
来源:
PHYSICAL THERAPY & REHABILITATION JOURNAL
摘要:
经过验证的自我报告 LEL 问卷对于 LEL 的评估和诊断非常重要。本研究的目的是验证和翻译荷兰语版本的筛查问卷,即由 Yost 等人开发和验证的 LELSQ。方法:我们对一组健康女性和一组诊断为 LEL 的患者测试了问卷。使用正向和反向方法从英语到荷兰语进行翻译。在验证过程中使用SPSS (IBM corp, Armonk, New York, NY, USA)版本28.0.1.0 (001)进行统计分析。通过确定 Cronbach's alpha 来评估内部一致性。可靠性通过重测信度进行检验。通过ROC分析确定效度,并评估内容效度和表面效度。两组的内部一致性得分均具有很强的值(0.83至0.90)。两组的重测可靠性也很强。表面效度和内容效度表明 LELSQ 是一种简单易懂的调查问卷,在 LEL 的早期检测中并不太耗时。 ROC分析显示AUC值为0.93,效度较强。经验证的荷兰语翻译显示出较高的内部一致性、重测信度和效度,使我们能够将问卷应用于妇科癌症治疗后LEL的早期检测。
Validated questionnaires of self-reported LEL are important in the assessment and diagnosis of LEL. The aim of this study was to validate and translate a Dutch version of the screening questionnaire, the LELSQ developed and validated by Yost et al. Methods: We tested the questionnaire on a group of healthy women and a group of patients diagnosed with LEL. The translation was carried out using the forward and backward method from English to Dutch.SPSS (IBM corp, Armonk, New York, NY, USA) version 28.0.1.0 (001) was used for statistical analysis in the process of validation. The internal consistency was assessed by determining Cronbach's alpha. The reliability was tested by test-retest reliability. The validity was determined by ROC analysis, and content and face validity were evaluated.The internal consistency score in both groups had a strong value (0.83 to 0.90). The test-retest reliability was also strong in both groups. Face and content validity showed the LELSQ is an easy, understandable questionnaire that is not too time-consuming in the early detection of LEL. The ROC analysis showed an AUC value of 0.93, indicating strong validity.The validated Dutch translation showed high values for internal consistency, test-retest reliability, and validity, which allows us to implement the questionnaire in the early detection of LEL after gynecological cancer treatment.